NPCE
NeuroPace Inc · Healthcare · Market cap $497.7M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$399K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Sep 4, 2026
Morrell Martha
NeuroPace Inc (NPCE) has 41 SEC Form 4 filings (42 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Sep 4, 2026.
Inside the rolling window, 1 insider at NeuroPace Inc reported no open-market purchases and 1 open-market sale totaling $399K. The most recent open-market filing is a sale of 25,000 shares by CHIEF MEDICAL OFFICER Morrell Martha, dated Dec 15, 2025, worth $399K.
- Industry:Medical - Devices
- CEO:Joel D. Becker
- Employees:220
- HQ:Mountain View, CA, US
- IPO:2021-04-22
| Source | |||||||
|---|---|---|---|---|---|---|---|
Morrell MarthaFirst filing | CHIEF MEDICAL OFFICER | Sale | 25,000 | $399K | Mar 4 | +3.9% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does NPCE have?
NeuroPace Inc (NPCE) has 41 SEC Form 4 filings (42 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for NPCE?
The most recent Form 4 filing for NPCE on Tracefour is dated Sep 4, 2026.
What is the total insider buy and sell value at NPCE in the current window?
Inside the rolling window, insiders at NPCE bought $0 and sold $399K based on SEC Form 4 filings.
Can I get alerts for NPCE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at NeuroPace Inc (NPCE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
NeuroPace Inc is in the Healthcare sector.